These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1318093)
1. Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by a nonspecific site interaction mechanism. Young HS; Skita V; Mason RP; Herbette LG Biophys J; 1992 May; 61(5):1244-55. PubMed ID: 1318093 [TBL] [Abstract][Full Text] [Related]
2. Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors. Herbette LG; Vant Erve YM; Rhodes DG J Mol Cell Cardiol; 1989 Feb; 21(2):187-201. PubMed ID: 2545886 [TBL] [Abstract][Full Text] [Related]
3. Partitioning and location of Bay K 8644, 1,4-dihydropyridine calcium channel agonist, in model and biological membranes. Mason RP; Gonye GE; Chester DW; Herbette LG Biophys J; 1989 Apr; 55(4):769-78. PubMed ID: 2470429 [TBL] [Abstract][Full Text] [Related]
4. Comparison of location and binding for the positively charged 1,4-dihydropyridine calcium channel antagonist amlodipine with uncharged drugs of this class in cardiac membranes. Mason RP; Campbell SF; Wang SD; Herbette LG Mol Pharmacol; 1989 Oct; 36(4):634-40. PubMed ID: 2554114 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma. Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site. Rhodes DG; Sarmiento JG; Herbette LG Mol Pharmacol; 1985 Jun; 27(6):612-23. PubMed ID: 2987659 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer. Mason RP; Moisey DM; Shajenko L Mol Pharmacol; 1992 Feb; 41(2):315-21. PubMed ID: 1531693 [TBL] [Abstract][Full Text] [Related]
9. Rat cerebral cortical synaptoneurosomal membranes. Structure and interactions with imidazobenzodiazepine and 1,4-dihydropyridine calcium channel drugs. Moring J; Shoemaker WJ; Skita V; Mason RP; Hayden HC; Salomon RM; Herbette LG Biophys J; 1990 Aug; 58(2):513-31. PubMed ID: 1698472 [TBL] [Abstract][Full Text] [Related]
10. Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: propranolol, nimodipine and amiodarone. Herbette LG; Trumbore M; Chester DW; Katz AM J Mol Cell Cardiol; 1988 May; 20(5):373-8. PubMed ID: 3210248 [TBL] [Abstract][Full Text] [Related]
11. Interactions of cryptosin with mammalian cardiac dihydropyridine-specific calcium channels. Rao VR; Banning JW Life Sci; 1990; 47(18):1667-76. PubMed ID: 2174493 [TBL] [Abstract][Full Text] [Related]
12. Dihydropyridine receptor in rat brain labeled with [3H]nimodipine. Bellemann P; Schade A; Towart R Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2356-60. PubMed ID: 6300912 [TBL] [Abstract][Full Text] [Related]
13. [3H]nimodipine specific binding to cardiac myocytes and subcellular fractions. DePover A; Lee SW; Matlib MA; Whitmer K; Davis BA; Powell T; Schwartz A Biochem Biophys Res Commun; 1983 May; 113(1):185-91. PubMed ID: 6860335 [TBL] [Abstract][Full Text] [Related]
14. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma. Haase H; Wallukat G; Vetter R; Will H Biomed Biochim Acta; 1987; 46(8-9):S363-9. PubMed ID: 2829862 [TBL] [Abstract][Full Text] [Related]
15. Receptor model for the molecular basis of tissue selectivity of 1, 4-dihydropyridine calcium channel drugs. Langs DA; Strong PD; Triggle DJ J Comput Aided Mol Des; 1990 Sep; 4(3):215-30. PubMed ID: 2177783 [TBL] [Abstract][Full Text] [Related]
16. Interaction of charged and uncharged calcium channel antagonists with phospholipid membranes. Binding equilibrium, binding enthalpy, and membrane location. Bäuerle HD; Seelig J Biochemistry; 1991 Jul; 30(29):7203-11. PubMed ID: 1830218 [TBL] [Abstract][Full Text] [Related]
17. Substituted diphenylbutylpiperidines bind to a unique high affinity site on the L-type calcium channel. Evidence for a fourth site in the cardiac calcium entry blocker receptor complex. King VF; Garcia ML; Shevell JL; Slaughter RS; Kaczorowski GJ J Biol Chem; 1989 Apr; 264(10):5633-41. PubMed ID: 2538426 [TBL] [Abstract][Full Text] [Related]
18. Fluorescent probing with felodipine of the dihydropyridine receptor and its interaction with the ryanodine receptor calcium release channel. Minarovic I; Mészáros LG Biochem Biophys Res Commun; 1998 Mar; 244(2):519-24. PubMed ID: 9514900 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of [3H]nimodipine binding to sarcolemmal membranes from rat vas deferens and its regulation by guanine nucleotide. Higo K; Saito H; Matsuki N Jpn J Pharmacol; 1988 Oct; 48(2):213-21. PubMed ID: 2850380 [TBL] [Abstract][Full Text] [Related]
20. Favorable amphiphilicity of nimodipine facilitates its interactions with brain membranes. Herbette LG; Mason PE; Sweeney KR; Trumbore MW; Mason RP Neuropharmacology; 1994 Feb; 33(2):241-9. PubMed ID: 8035910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]